On March 21, the British Gov. web announced that three procurement contracts for COVID-19 antigen reagents. Orient Gene, ACON Biotech and Getein Biotech indirectly won the contracts of ¡ê 595 million, ¡ê 237.8 million and ¡ê 85 million respectively. The three contracts start on February 23 and the deadline is August 20.
The 3 companies of TANNER PHARMA UK LIMITED, MEDCO SOLUTIONS LTD & PHARMACEUTICALS DIRECT LIMITED won the contracts of antigen reagents announced by British Gov. with values of ¡ê 595 million, ¡ê 237.8 million and ¡ê 85 million respectively. Orient Gene shares 65% on the total value of ¡ê 917.8 million.
¡ê 917.8 million equals to 7.7 billion CNY.
The signed contract with TANNER PHARMA UK LIMITED is about 5 billion CNY, which is to supply the COVID-19 antigen self-test reagent to Health and Safety Executive (HSE) by Orient Gene. 2 billion CNY contract signed by MEDCO SOLUTIONS LTD & ACON Biotech is to supply the COVID-19 antigen self-test reagent to HSE. And Getein Biotech signed the contract with PHARMACEUTICALS DIRECT LIMITED.
